Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/18/2008CA2343116C Methods and compositions for increasing intestinal absorption of fats
11/18/2008CA2341366C Micronised pharmaceutical compositions
11/18/2008CA2338721C New cofactors for methyltransferases
11/18/2008CA2335686C Particulate acellular tissue matrix
11/18/2008CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/18/2008CA2281614C Monomers derived from hydroxy acids and polymers prepared therefrom
11/18/2008CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
11/18/2008CA2241941C Therapeutic agent containing .omega.-feline interferon for treating feline aids virus infections and feline atopic dermatitis
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/18/2008CA2210491C Antagonists of interleukin-15
11/18/2008CA2193993C New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
11/18/2008CA2172376C Antibodies to cd40
11/18/2008CA2157975C Recombinant mersacidin and a method for production
11/18/2008CA2156495C Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells
11/18/2008CA2124161C Pharmaceuticals for treating sepsis and septic shock
11/18/2008CA2107884C Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
11/18/2008CA2102234C Peritoneal dialysis composition and method usable during and after peritonitis
11/18/2008CA1341585C Recombinant retroviruses
11/18/2008CA1341583C Interferons and process for their preparation
11/13/2008WO2008138001A2 Synthetic peptides and peptide mimetics
11/13/2008WO2008137834A2 Crystal structure of smyd3 protein
11/13/2008WO2008137787A2 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008WO2008137720A2 Peptide analogs that are potent and selective for human neurotensin receptor subtype 2
11/13/2008WO2008137633A2 Methods of modulating cellular homeostatic pathways and cellular survival
11/13/2008WO2008137617A1 Use of cyclosporines in the treatment of patients with intraocular lenses
11/13/2008WO2008137574A1 Compositions and methods for increasing vascularization
11/13/2008WO2008137571A1 Methods of treating neurodegenerative diseases
11/13/2008WO2008137471A2 Modified interferon beta polypeptides and their uses
11/13/2008WO2008137281A1 Compositions and methods for altering pancreas or liver function
11/13/2008WO2008137118A1 Suppression of inflammation associated with transplantation using an epsilon pkc inhibitor
11/13/2008WO2008137054A2 Composition for transmucosal delivery of polypeptides
11/13/2008WO2008137043A1 Methods and compositions
11/13/2008WO2008136869A2 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
11/13/2008WO2008136820A1 Stabilization of mammalian membrane proteins by short surfactant peptides
11/13/2008WO2008136759A1 Stabilized suspension
11/13/2008WO2008136689A1 Kiwifruit compositions
11/13/2008WO2008136547A1 Method of preventing or treating body weight disorders by employing clusterin
11/13/2008WO2008136541A1 Angiogenesis inhibitor comprising meteorin as an active ingredient
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008136511A1 Therapeutic agent for diabetic neuropathy
11/13/2008WO2008136438A1 Viral vector for gene therapy
11/13/2008WO2008136398A1 Cell culture method using amino acid-enriched medium
11/13/2008WO2008136397A1 Composition for prevention and/or treatment of peptic ulcer
11/13/2008WO2008135993A1 Klotho protein and related compounds for the treatment and diagnosis of cancer
11/13/2008WO2008135983A2 Recombinant human fibrinogen for treatment of bleeding in trauma and platelet disorders
11/13/2008WO2008135963A2 Fibrinogen for treatment of bleeding in trauma and platelet disorders
11/13/2008WO2008135793A1 Combination of aplidine and carboplatin in anticancer treatments
11/13/2008WO2008135790A1 Biologically active c-terminal fragment of acetylcholinesterase
11/13/2008WO2008135562A1 Self-precipitating pharmaceutical formulations for the modified release of active principle
11/13/2008WO2008135500A1 High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant
11/13/2008WO2008135419A2 Anti-il-6-agents for improving primary functioning of allogenic grafts
11/13/2008WO2008135239A1 PHARMACEUTICAL COMPOSITION FOR INCREASING INSULIN SECRETION FROM PANCREATIC β-CELLS
11/13/2008WO2008135237A1 Complement factor h-derived short consensus repeat-antibody constructs
11/13/2008WO2008135207A1 Implantable system for an intervertebral disc and intervertebral disc implant
11/13/2008WO2008134882A1 Methods and compositions for use of cyclic analogues of histatin
11/13/2008WO2008134879A1 Il-12 immunotherapy for cancer
11/13/2008WO2008115478A3 Method of cancer detection and treatment
11/13/2008WO2008109397A3 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
11/13/2008WO2008107862A3 Use of ngf for the preparation of medicaments for the cure of reactive gliosis
11/13/2008WO2008100584A3 Compositions and methods of treating neoplasia
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008083326A3 Targeting of ews-fli1 as anti-tumor therapy
11/13/2008WO2008082889A3 Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat
11/13/2008WO2008082438A3 Chd5 is a novel tumor suppressor gene
11/13/2008WO2008079030A8 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
11/13/2008WO2008076437A9 Activin-actrii antagonists and uses for increasing red blood cell levels
11/13/2008WO2008073988A3 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders
11/13/2008WO2008067057A3 Cancer treatment
11/13/2008WO2008064910A3 Metastasis-specific peptides and their diagnostic and therapeutic applications
11/13/2008WO2008045976A3 Compositions and methods for treating and diagnosing cancers
11/13/2008WO2008042024A3 Neuroactive fragments of app
11/13/2008WO2008039415A3 Analogs of ghrelin substituted at the n-terminal
11/13/2008WO2008036761A3 Anti-microbial defensin-related peptides and methods of use
11/13/2008WO2008033910A3 Punctum: drug delivery site for therapeutic peptides and proteins
11/13/2008WO2008030968A3 Fusion peptide therapeutic compositions
11/13/2008WO2008030543A3 Tyrosine, serine and threonine phosphorylation sites
11/13/2008WO2008021956A3 Acylaminoheteroaryl hepatitis c virus protease inhibitors
11/13/2008WO2008021733A3 Tetrazolyl acyclic hepatitis c serine protease inhibitors
11/13/2008WO2008021160B1 Regulation of litaf modulated cytokine production by a novel p53 short peptide
11/13/2008WO2008019266A3 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors
11/13/2008WO2008011335A3 Metal binding compounds, metal binding compositions, and their uses
11/13/2008WO2007118292A8 MEMBRANE PROTEIN Sm29 OF SCHISTOSOMA MANSONI AND USES THEREOF FOR TREATING AND DIAGNOSING SCHISTOSOMIASIS
11/13/2008WO2007109303A3 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
11/13/2008WO2007101094A3 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
11/13/2008WO2007100904A3 Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
11/13/2008WO2007098127A3 Compositions for treating wounds and processes for their preparation
11/13/2008WO2007081302A3 Human glp-1 mimetibodies, compositions, methods and uses
11/13/2008WO2007078839A3 Compounds, compositions and methods
11/13/2008WO2007030307A3 Method of treating glaucoma
11/13/2008WO2007026356A3 Methods and compositions for prevention and treatment of diabetic and aged skin
11/13/2008WO2007014497A8 A composition comprising silver nanoparticles and the use thereof
11/13/2008WO2006017251A3 Compositions for delivering peptide yy and pyy agonists
11/13/2008WO2005094424A3 Use of the pro-peptide domain of lysyl oxidase as a therapeutic agent
11/13/2008WO2004080283A3 Type 1 ryanodine receptor-based methods
11/13/2008US20080281084 Using charged polymers to enhance solubility of polypeptide in aqueous solutions
11/13/2008US20080281079 Bioactivation Of Particles
11/13/2008US20080280846 2', 3'-dideoxynucleoside analogues for the treatment or prevention of flaviviridae infections
11/13/2008US20080280835 Peptides illustrated by lacosamide ((R)-2-acetamide-N-benzyl-3-methoxypropionamide)
11/13/2008US20080280834 Compounds and methods for inhibiting apoptosis
11/13/2008US20080280833 amino acid motif GAAG; polypeptide that inhibits cell migration, cell adhesion, cell proliferation and/or cell differentiation; anticancer; adenocarcinoma, leukemia, lymphoma, or myeloma; inhibitor of chemotaxis
1 ... 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 ... 3163